Transmedics
TMDX
64 hedge funds and large institutions have $387M invested in Transmedics in 2019 Q2 according to their latest regulatory filings, with 64 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
65.63% more ownership
Funds ownership: 0% → 65.63% (+66%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Abrams Capital Management
Boston,
Massachusetts
|
+$95.5M |
| 2 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$69.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$64.8M |
| 4 |
Credit Suisse
Zurich,
Switzerland
|
+$17.8M |
| 5 |
ZP
Zimmer Partners
New York
|
+$14.7M |
Top Sellers
TMDX Hedge Fund Activity: Q2 2019 in Review
64 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q2 2019, worth a combined $387M.
Buyers outnumbered sellers: 64 funds opened new TMDX positions and 0 closed out — a net gain of 64 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Abrams Capital Management, opening a new position worth an estimated $95.5M.
- 64 institutional investors held Transmedics (TMDX) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $387M of Transmedics stock for Q2 2019.
- 64 funds opened new Transmedics positions in Q2 2019 and 0 closed out, a net change of +64 holders.
- The largest Transmedics buyer in Q2 2019 was Abrams Capital Management, an estimated $95.5M added.
Based on aggregated 13F filings for Q2 2019.